首页> 外国专利> APPROPRIATE FLUOROBENZAMIDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR SENILE DEMENTIA.

APPROPRIATE FLUOROBENZAMIDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR SENILE DEMENTIA.

机译:适当的氟苯甲酰胺类药物治疗老年痴呆症或老年性痴呆。

摘要

Compounds of the general formula ** (See formula) ** wherein R1 is hydrogen, (C1-C6) -alkyl or hydroxy- (C1-C6) -alkyl; R2 is (C1-C6) -alkyl, -CO-NR 8 R 9, - (CH2) n-NR8 R9, - (CH2) P-OR 8, or - (CH2) n-CN; R3 is selected from hydrogen, halogen, halogen- (C1-C6) -alkyl, cyano, C1-C6-alkoxy or halogen- (C1-C6) -alkoxy; R4, R5, R6 and R7 are hydrogen or fluorine, and at least one of R4, R5, R6 and R7 is fluorine; R8 and R9 independently of each other are hydrogen or (C1-C6) -alkyl; m is 1, 2 or 3; n is 0, 1, 2 or 3; and p is 1 or 2; as well as its pharmaceutically acceptable salts.
机译:通式**的化合物(参见式)**其中R 1为氢,(C 1 -C 6)-烷基或羟基-(C 1 -C 6)-烷基; R2为(C1-C6)-烷基,-CO-NR 8 R 9,-(CH2)n-NR8 R9,-(CH2)P-OR 8或-(CH2)n-CN; R3选自氢,卤素,卤素-(C1-C6)-烷基,氰基,C1-C6-烷氧基或卤素-(C1-C6)-烷氧基; R4,R5,R6和R7为氢或氟,R4,R5,R6和R7中的至少一个为氟; R8和R9彼此独立地是氢或(C1-C6)-烷基; m为1、2或3; n为0、1、2或3; p为1或2;及其药学上可接受的盐。

著录项

  • 公开/公告号ES2322254T3

    专利类型

  • 公开/公告日2009-06-18

    原文格式PDF

  • 申请/专利权人 F. HOFFMANN-LA ROCHE AG;

    申请/专利号ES20030735578T

  • 申请日2003-06-07

  • 分类号A61P3/04;C07C233/83;A61K31/16;A61K31/165;A61K31/166;A61K31/275;A61K31/277;A61P25;A61P25/02;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/34;A61P43;C07B53;C07C;C07C1;C07C231/02;C07C231/14;C07C231/16;C07C233/65;C07C233/69;C07C235/48;C07C235/50;C07C237/06;C07C253/30;C07C255/24;C07C255/29;C07C255/44;C07C255/55;

  • 国家 ES

  • 入库时间 2022-08-21 19:23:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号